The Assessment and Treatment of Antipsychotic-Induced Akathisia

被引:37
|
作者
Pringsheim, Tamara [1 ]
Gardner, David [2 ]
Addington, Donald [3 ]
Martino, Davide [4 ]
Morgante, Francesca [5 ,6 ]
Ricciardi, Lucia [7 ]
Poole, Norman [8 ]
Remington, Gary [9 ,10 ]
Edwards, Mark [11 ]
Carson, Alan [12 ]
Barnes, Thomas R. E. [13 ]
机构
[1] Univ Calgary, Dept Clin Neurosci Psychiat Pediat & Community Hl, Calgary, AB, Canada
[2] Dalhousie Univ, Dept Psychiat & Pharm, Halifax, NS, Canada
[3] Univ Calgary, Dept Psychiat, Calgary, AB, Canada
[4] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[5] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[6] St Georges Univ London, Inst Mol & Clin Sci, London, England
[7] St Georges Univ London, Inst Cardiovasc & Cell Sci, London, England
[8] Kings Coll London, Dept Philosophy, London, England
[9] Univ Toronto, CAMH, Schizophrenia Div, Dept Psychiat, Toronto, ON, Canada
[10] Univ Toronto, CAMH, Schizophrenia Div, Dept Psychol Clin Sci, Toronto, ON, Canada
[11] St Georges Univ London, Dept Neurol, London, England
[12] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland
[13] Imperial Coll London, Dept Psychiat, London, England
关键词
antipsychotics; extrapyramidal syndromes; evidence-based medicine; NEUROLEPTIC-INDUCED AKATHISIA; INDUCED MOVEMENT-DISORDERS; LOW-DOSE MIRTAZAPINE; DOUBLE-BLIND; TARDIVE-DYSKINESIA; RATING-SCALE; WITHDRAWAL AKATHISIA; BARNES AKATHISIA; CONTROLLED TRIAL; PLACEBO;
D O I
10.1177/0706743718760288
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Akathisia is a common and distressing neuropsychiatric syndrome associated with antipsychotic medication, characterised by subjective and objective psychomotor restlessness. The goal of this guideline is to provide clinicians with recommendations on the assessment and treatment of akathisia. Methods: We performed a systematic review of therapeutic studies assessing the treatment of antipsychotic-induced extrapyramidal symptoms. Forty studies on akathisia and 4 systematic reviews evaluating the adverse effects of antipsychotics were used in the formulation of recommendations. Studies were rated for methodological quality using the American Academy of Neurology Risk of Bias Classification system. The overall level of evidence classifications and grades of recommendation were made using the Scottish Intercollegiate Guidelines Network framework. Results: As a good practice point, clinicians should systematically assess akathisia with a validated scale before starting antipsychotics and during antipsychotic dosage titration. For the management of akathisia, there was adequate evidence to allow recommendations regarding antipsychotic dose reduction, antipsychotic polypharmacy, switching antipsychotic medication, and the use of adjuvant medications including beta-blockers, anticholinergics, 5HT(2A) antagonists, benzodiazepines, and vitamin B6. Conclusion: The treatment of antipsychotic-induced akathisia should be personalised, with consideration of antipsychotic dose reduction, cessation of antipsychotic polypharmacy, and switching to an antipsychotic with a perceived lower liability for akathisia, before the use of adjuvant medications. The choice of adjuvant medications should favour the more established treatments, with careful consideration of contraindications and side effects. Limitations in the evidence should be acknowledged and prompt cautious prescribing, particularly with respect to the duration of use of adjuvant medications, is warranted.
引用
收藏
页码:719 / 729
页数:11
相关论文
共 50 条
  • [21] The Relationship Between Antipsychotic-Induced Akathisia and Suicidal Behaviour: A Systematic Review
    Kalniunas, Arturas
    Chakrabarti, Ipsita
    Mandalia, Rakhee
    Munjiza, Jasna
    Pappa, Sofia
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 3489 - 3497
  • [22] Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists
    Poyurovsky, Michael
    Weizman, Abraham
    DRUGS, 2020, 80 (09) : 871 - 882
  • [23] Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists
    Michael Poyurovsky
    Abraham Weizman
    Drugs, 2020, 80 : 871 - 882
  • [24] BETA-ADRENERGIC BLOCKING-AGENTS FOR ANTIPSYCHOTIC-INDUCED AKATHISIA
    DOLE, E
    WELLS, BG
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (7-8): : 618 - 619
  • [25] Treatment of Antipsychotic-Induced Sialorrhea
    Glick, Amy R.
    Khan, Imran A.
    Sher, Leo
    PSYCHIATRIC ANNALS, 2014, 44 (06) : 267 - 269
  • [26] Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia A Systematic Review and Network Meta-Analysis
    Gerolymos, Cyril
    Barazer, Romain
    Yon, Dong Keon
    Loundou, Anderson
    Boyer, Laurent
    Fond, Guillaume
    JAMA NETWORK OPEN, 2024, 7 (03) : E241527
  • [27] Antipsychotic-induced akathisia and neuroleptic malignant syndrome in anti-NMDAR encephalitis
    Mohammad, Shekeeb S.
    Wallace, Geoffrey
    Ramanathan, Sudarshini
    Brilot, Fabienne
    Dale, Russell C.
    ANNALS OF CLINICAL PSYCHIATRY, 2014, 26 (04) : 297 - 298
  • [28] Clinical characteristics and associated factors in antipsychotic-induced akathisia of Asian patients with schizophrenia
    Chong, SA
    Mythily
    Remington, G
    SCHIZOPHRENIA RESEARCH, 2003, 59 (01) : 67 - 71
  • [29] Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review
    Nasyrova, Regina F.
    Vaiman, Elena E.
    Repkina, Vera V.
    Khasanova, Aiperi K.
    Asadullin, Azat R.
    Shipulin, German A.
    Altynbekov, Kuanysh S.
    Al-Zamil, Mustafa
    Petrova, Marina M.
    Shnayder, Natalia A.
    GENES, 2023, 14 (03)
  • [30] Metformin in the Treatment of Antipsychotic-induced Amenorrhea
    Baumgarten, E.
    Gahr, M.
    NERVENHEILKUNDE, 2013, 32 (08) : 554 - 558